Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,702 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment strategy and clinical outcome in Japanese patients with atrial fibrillation.
Suzuki S, Yamashita T, Otsuka T, Sagara K, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Ogasawara K, Sawada H, Yamazaki T, Aizawa T. Suzuki S, et al. Among authors: yamazaki t. Heart Vessels. 2009 Jul;24(4):287-93. doi: 10.1007/s00380-008-1121-2. Epub 2009 Jul 22. Heart Vessels. 2009. PMID: 19626402
Investigation of the optimal treatment strategy for atrial fibrillation in Japan.
Yamashita T, Ogawa S, Aizawa Y, Atarashi H, Inoue H, Ohe T, Okumura K, Kato T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H, Yamazaki T; J-RHYTHM Investigators. Yamashita T, et al. Among authors: yamazaki t. Circ J. 2003 Sep;67(9):738-41. doi: 10.1253/circj.67.738. Circ J. 2003. PMID: 12939546 Free article. Clinical Trial.
Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension.
Yamashita T, Ogawa S, Aizawa Y, Atarashi H, Inoue H, Ohe T, Okumura K, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E; J-RHYTHM II Investigators. Yamashita T, et al. Among authors: yamazaki t. Circ J. 2006 Oct;70(10):1318-21. doi: 10.1253/circj.70.1318. Circ J. 2006. PMID: 16998266 Free article. Clinical Trial.
Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study.
Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, Ohe T, Ohtsu H, Okumura K, Katoh T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Tabuchi T, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H; J-RHYTHM Investigators. Ogawa S, et al. Among authors: yamazaki t. Circ J. 2009 Feb;73(2):242-8. doi: 10.1253/circj.cj-08-0608. Epub 2008 Dec 8. Circ J. 2009. PMID: 19060419 Free article. Clinical Trial.
Body size and atrial fibrillation in Japanese outpatients.
Suzuki S, Yamashita T, Ohtsuka T, Sagara K, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Ogasawara K, Sawada H, Yamazaki T, Aizawa T. Suzuki S, et al. Among authors: yamazaki t. Circ J. 2010 Jan;74(1):66-70. doi: 10.1253/circj.cj-09-0431. Epub 2009 Oct 2. Circ J. 2010. PMID: 19797821 Free article.
Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events.
Teramoto T, Shimada K, Uchiyama S, Sugawara M, Goto Y, Yamada N, Oikawa S, Ando K, Ishizuka N, Yamazaki T, Yokoyama K, Murata M, Ikeda Y. Teramoto T, et al. Among authors: yamazaki t. Am Heart J. 2010 Mar;159(3):361-369.e4. doi: 10.1016/j.ahj.2009.11.030. Am Heart J. 2010. PMID: 20211296 Clinical Trial.
3,702 results